找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine Therapy of Breast Cancer III; Franco Cavalli Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 breast cancer.ca

[復(fù)制鏈接]
樓主: KEN
11#
發(fā)表于 2025-3-23 10:32:37 | 只看該作者
https://doi.org/10.1007/978-1-4419-9096-9orly defined, we have generalised our method of comparing treatment attitudes to include individual qualitative judgment values. The generalisation includes: 1) a comparison of two populations based upon an overall value given to each period of life either with or without breast cancer related event
12#
發(fā)表于 2025-3-23 14:44:48 | 只看該作者
13#
發(fā)表于 2025-3-23 21:02:15 | 只看該作者
Control of Follicular Growth and Ovulationsm of oestradiol action to full oestrogen agonist effects in both animals and man [1,5]. This complex pharmacology raises a number of issues of importance to the therapeutic use of antioestrogens and, at a more fundamental level, to our understanding of the mode of action of oestrogens.
14#
發(fā)表于 2025-3-24 00:54:29 | 只看該作者
Progression from Steroid Responsive to Unresponsive State in Breast Cancer,nd different degrees of hormone sensitivity [3–5] have been helpful at the biological level but have not defined any of the underlying molecular events. Figure 1 depicts a generally accepted version of the current status of multi-pathway evolution of unresponsive tumours which will form the basis of
15#
發(fā)表于 2025-3-24 03:25:14 | 只看該作者
Integration of Quality-of-Life Issues into Clinical Trials of Breast Cancer,orly defined, we have generalised our method of comparing treatment attitudes to include individual qualitative judgment values. The generalisation includes: 1) a comparison of two populations based upon an overall value given to each period of life either with or without breast cancer related event
16#
發(fā)表于 2025-3-24 07:57:28 | 只看該作者
17#
發(fā)表于 2025-3-24 10:49:59 | 只看該作者
18#
發(fā)表于 2025-3-24 17:58:00 | 只看該作者
19#
發(fā)表于 2025-3-24 22:25:31 | 只看該作者
Drug Resistance,Normal cells and tissues are provided with selective means to protect them against endogenous substances produced in excess in the body or against toxic exogenous substances.
20#
發(fā)表于 2025-3-25 00:26:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 01:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宁陕县| 阿拉善盟| 全椒县| 巍山| 大名县| 宁远县| 柘城县| 洛隆县| 三江| 乌拉特中旗| 翁牛特旗| 赣榆县| 新昌县| 锦州市| 银川市| 张掖市| 墨脱县| 大英县| 宜都市| 讷河市| 惠水县| 蓬莱市| 探索| 辰溪县| 台东县| 平潭县| 抚松县| 德令哈市| 商河县| 阿图什市| 潍坊市| 南川市| 金阳县| 乌苏市| 南宫市| 安国市| 沂源县| 黄浦区| 南平市| 兖州市| 崇州市|